Fig. 1: Patient disposition.
aFour patients with sqNSCLC and six patients with non-sqNSCLC were randomized to gotistobart 3 mg kg−1 before termination by the DMC.
Fig. 1: Patient disposition. | Nature Medicine
aFour patients with sqNSCLC and six patients with non-sqNSCLC were randomized to gotistobart 3 mg kg−1 before termination by the DMC.
